Skip to content

A study for assessment of low-doses nalmefene reduce remifentanil-induced postoperative hyperalgesia and enhance analgesia

A study for assessment of low-doses nalmefene reduce remifentanil-induced postoperative hyperalgesia and enhance analgesia

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023146
Enrollment
Unknown
Registered
2019-05-13
Start date
2019-05-14
Completion date
Unknown
Last updated
2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Analgesia of Colorectal Surgery

Interventions

Group N1:Use Nalmefene0.05µg/kg
Group N2:Use Nalmefene0.15µg/kg
Group N3:Use Nalmefene0.25µg/kg

Sponsors

The Second Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Open colorectal surgery lasting at least 2 h; 2. All had American Society of Anesthesiologists physical status I–III.

Exclusion criteria

Exclusion criteria: 1. Immediate extubation was not planned after surgery; 2. With chronic inflammatory disease including inflammatory bowel disease; 3. With a history of drug or alcohol abuse; 4. With contraindications to the self-administration of opioids (i.e., unable to understand the patient-controlled analge- sia [PCA] device); 5. With a history of psychiatric disorder; 6. With severe liver and kidney dysfunction.

Design outcomes

Primary

MeasureTime frame
Visual analog scale;

Countries

China

Contacts

Public ContactXiao Zhao Yang

The Second Hospital of Dalian Medical University

xiaozhaoy2012@163.com+86 17709873399

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026